Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

Jump to content

2,3-Methylenedioxymethamphetamine

From Wikipedia, the free encyclopedia
ORTHO-MDMA
Clinical data
Other names2,3-MDMA; 2,3-Methylenedioxy-N-methylamphetamine; ORTHO-MDMA
ATC code
  • None
Identifiers
  • 1-(1,3-Benzodioxol-4-yl)-N-methylpropan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC11H15NO2
Molar mass193.246 g·mol−1
3D model (JSmol)
  • CC(CC1=C2C(=CC=C1)OCO2)NC
  • InChI=1S/C11H15NO2/c1-8(12-2)6-9-4-3-5-10-11(9)14-7-13-10/h3-5,8,12H,6-7H2,1-2H3/t8-/m0/s1 checkY
  • Key:RTZIIFGBTSUSEL-QMMMGPOBSA-N checkY

2,3-Methylenedioxymethamphetamine, also known as 2,3-MDMA or ORTHO-MDMA, is a positional isomer of the recreational drug 3,4-MDMA (commonly known as Ecstasy or Molly).[1] It is a monoamine transporter (MAT) substrate and inhibitor similarly to 3,4-MDMA.[2] However, while showing similar potency at the norepinephrine transporter (NET), 2,3-MDMA is less potent at the serotonin transporter (SERT).[2] 2,3-MDMA has not been encountered as a recreational or designer drug.[2]

See also

[edit]

References

[edit]
  1. Cody JT, Valtier S (2002). "Differentiation of the 2,3-methylenedioxy regioisomer of 3,4-MDMA (ecstasy) by gas chromatography-mass spectrometry". J. Anal. Toxicol. 26 (7): 537–539. doi:10.1093/jat/26.7.537. PMID 12423014.
  2. 1 2 3 Montgomery T, Buon C, Eibauer S, Guiry PJ, Keenan AK, McBean GJ (December 2007). "Comparative potencies of 3,4-methylenedioxymethamphetamine (MDMA) analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines". Br J Pharmacol. 152 (7): 1121–1130. doi:10.1038/sj.bjp.0707473. PMC 2095113. PMID 17891159.
[edit]